What makes DOT work?

Lancet

Volumn 352, Issue 9137, 1998, Pages 1326-1327

  Garner, P ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

HUMAN; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SHORT SURVEY; TUBERCULOSIS; COMPARATIVE STUDY; DRUG SELF ADMINISTRATION; LUNG TUBERCULOSIS; NOTE; OBSERVATION;

ANTITUBERCULAR AGENTS; HUMANS; OBSERVATION; SELF ADMINISTRATION; TUBERCULOSIS, PULMONARY;

EID: 0032564138     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60739-8     Document Type: Note

References (7)

1. Global Tuberculosis Programme: treatment of tuberculosis 1997 WHO Report Geneva, Switzerland WHO/TB/97.220
2. World Health Organization. WHO press release, 21 March 1997; WHO/24.
3. CP Chaulk VH Kazanjjian Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel JAMA 27 1998 943 948
4. J Volmink P Garner Promoting adherence to tuberculosis treatment. Cochrane Library (CDRom and Online), Cochrane Collaboration; Issue 3 1998 Update Software Oxford
5. W El-Sadr F Meard V Barhaud Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993 Am J Publ Health 86 1996 1146 1149
6. CP Chaulk K Moore-Rice R Rizzo RE Chaisson Eleven years of community-based directly observed therapy for tuberculosis JAMA 274 1995 945 951
7. P Garner J Volmink Directly observed therapy Lancet 350 1997 666 667